Aileron Therapeutics Announces CEO Transition

Current President and Chief Operating Officer, Brian Windsor, Ph.D., appointed Chief Executive OfficerDr. Windsor to lead Aileron into a new era f...

Related Keywords

Texas ,United States ,Brian Windsor ,Manuel Aivado ,Emergent Technologies Inc ,University Of Texas At Austin ,Aileron Therapeutics Inc ,Pharmaceuticals Inc ,Company Board Of Directors ,Company Annual Report On Form ,Exchange Commission ,Lung Therapeutics Inc ,Current President ,Chief Operating Officer ,Chief Executive ,Chief Executive Officer ,Lung Therapeutics ,Chief Science Officer ,Emergent Technologies ,Managing Director ,Molecular Biology ,Orphan Drug Designation ,Fast Track Designation ,Aileron Therapeutics ,Private Securities Litigation Reform Act ,Nasdaq Stock Market ,Annual Report ,United States Securities ,Current Report ,Media Contact ,